Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Low Dose Aspirin in Type-2 Diabetic Patients With Very High Cardiovascular Risk and Subclinical Inflammation

NCT02164578 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT02164578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02164578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Low Dose Aspirin in Type-2 Diabetic Patients With Very High Cardiovascular Risk and Subclinical Inflammation
Lead sponsor
GWT-TUD GmbH
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2015
Completion date
April 30, 2020
Enrollment
179 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetic patients